CIK 0001140859 · Large accelerated filer
Cencora, Inc.
Sign in to watch- Ticker
- COR
- Exchange
- NYSE
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 233079390
- Phone
- 610-727-7000
- Business address
- 1 WEST FIRST AVENUE, CONSHOHOCKEN, PA, 19428
- Former names
- AMERISOURCEBERGEN CORP, AMERISOURCE BERGEN CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,020,270
- in 5 filings, $946K under 10b5-1 plans
Net −$5,020,270. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-01 | Donato Leslie E EVP & Chief Strategy Officer | Shares withheld for taxes | −533 | $233.53 | $124K | 9,457.85 |
| 2024-07-01 | Donato Leslie E EVP & Chief Strategy Officer | Option exercise · Restricted Stock Units | −1,432 | 0 | ||
| 2024-06-28 | Battaglia Silvana Executive Vice President | Grant or award | +66.28 | $191.51 | $13K | 12,421.08 |
| 2024-06-28 | Campbell Elizabeth S Executive Vice President | Grant or award | +57.9 | $191.51 | $11K | 8,304.32 |
| 2024-06-28 | Donato Leslie E EVP & Chief Strategy Officer | Grant or award | +66.88 | $191.51 | $13K | 9,524.73 |
| 2024-06-18 | COLLIS STEVEN H Chairman, President & CEO | Option exercise 10b5-1 | +10,754 | $89.58 | $963K | 295,842 |
| 2024-06-18 | COLLIS STEVEN H Chairman, President & CEO | Sale 10b5-1 | −10,754 | $235.76 | $2.5M | 285,088 |
| 2024-06-18 | COLLIS STEVEN H Chairman, President & CEO | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −10,754 | 86,036 | ||
| 2024-05-31 | Clark Gina Executive Vice President | Sale | −1,874 | $223.86 | $420K | 13,284 |
| 2024-05-29 | Clark Gina Executive Vice President | Option exercise 10b5-1 | +27,093 | $86.09 | $2.3M | 42,251 |
| 2024-05-29 | Clark Gina Executive Vice President | Sale 10b5-1 | −27,093 | $216.07 | $5.9M | 15,158 |
| 2024-05-29 | Clark Gina Executive Vice President | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −27,093 | 0 | ||
| 2024-05-24 | DURCAN DERMOT MARK Director | Purchase | +500 | $218.58 | $109K | 21,876 |
| 2024-05-22 | Walgreens Boots Alliance, Inc. 10% owner | Sale | −1,859,390 | $215.12 | $400.0M | 24,418,171 |
| 2024-05-21 | COLLIS STEVEN H Chairman, President & CEO | Option exercise 10b5-1 | +10,755 | $89.58 | $963K | 295,843 |
| 2024-05-21 | COLLIS STEVEN H Chairman, President & CEO | Sale 10b5-1 | −10,755 | $221.30 | $2.4M | 285,088 |
| 2024-05-21 | COLLIS STEVEN H Chairman, President & CEO | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −10,755 | 96,790 | ||
| 2024-05-01 | Tyler Lauren M Director | Grant or award | +110 | $229.20 | $25K | 1,673 |
| 2024-05-01 | Baumann Werner Director | Grant or award | +110 | $229.20 | $25K | 1,673 |
| 2024-05-01 | NALLY DENNIS M Director | Grant or award | +137 | $229.20 | $31K | 11,956 |
Page 21 of 41 · 815 trades